Richard Finn, MD, and David James Pinato, MD, MRCP, PhD, discuss driving forces for the development of hepatocellular carcinoma, including different types of viral hepatitis and non-alcoholic steatohepatitis.
Personalized Dosimetry With Y-90 Glass Microspheres Shows Positive Activity in HCC
Breast Cancer Experts Share Obstacles and Successes as Women in Oncology
ASCO GI Updates Provide Window Into Evolving HCC Treatment Paradigm
FDA Approval Insights: NALIRIFOX in Metastatic Pancreatic Cancer
The Billion Dollar Question in Ovarian Cancer: What Therapies to Use for Maintenance and Recurrence
McAndrew Expands on the Evolving Treatment Armamentarium in HER2+ Breast Cancer
Navigating the Intersection of Radiation Therapy and Immunotherapy in Endometrial Cancer
As Orthopedic Oncology Evolves, Caring for the Clinician Must Be a Priority
Belumosudil Produces Long-Term Responses Without New Safety Concerns in cGVHD
Prophylactic Itacitinib May Safely Mitigate CRS Following Axi-Cel Administration in Lymphoma